<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47360/1995-4484-2024-542-548</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-3641</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Определение вероятности спондилоартрита у пациентов с увеитом</article-title><trans-title-group xml:lang="en"><trans-title>Determining the probability of spondyloarthritis in patients with uveitis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5493-6045</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Годзенко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Godzenko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Годзенко Алла Александровна</p><p>125993, Москва, ул. Баррикадная, 2/1, стр. 1</p><p>115522, Москва, Каширское шоссе, 34а</p></bio><bio xml:lang="en"><p>Alla Godzenko</p><p>125993, Moscow, Barrikadnaya str., 2/1, building 1</p><p>115522, Moscow, Kashirskoye Highway, 34A</p></bio><email xlink:type="simple">alla1106@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2982-7418</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Разумова</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Razumova</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119021, Российская Федерация, Москва, ул. Россолимо, 11</p></bio><bio xml:lang="en"><p>119021, Moscow, Rossolimo str., 11</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4285-0869</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глухова</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Glukhova</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34а</p></bio><bio xml:lang="en"><p>115522, Moscow, Kashirskoye Highway, 34A</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России; ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation; V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт глазных болезней им. М.М. Краснова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>M.M. Krasnov Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>01</day><month>11</month><year>2024</year></pub-date><volume>62</volume><issue>5</issue><fpage>542</fpage><lpage>548</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Годзенко А.А., Разумова И.Ю., Глухова С.И., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Годзенко А.А., Разумова И.Ю., Глухова С.И.</copyright-holder><copyright-holder xml:lang="en">Godzenko A.A., Razumova I.Y., Glukhova S.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/3641">https://rsp.mediar-press.net/rsp/article/view/3641</self-uri><abstract><p>Увеиты – гетерогенная группа воспалительных заболеваний глаз, часть из которых может быть ассоциирована со спондилоартритом (СпА). Вероятность СпА зависит от клинических особенностей увеита. Цель исследования – разработать прогностическую формулу определения вероятности спондилоартрита у пациентов с увеитомМатериал и методы. Обследовано 208 пациентов (79 мужчин и 129 женщин) с разными формами увеитов, направленных офтальмологами в ФГБНУ НИИР им. В.А. Насоновой. Дебют увеита в возрасте не старше 30 лет состоялся у 107 (51,44%) из 208 пациентов, в возрасте старше 30 лет – у 101 (48,56%). У 139 из 208 больных зарегистрировано острое рецидивирующее течение увеита, у 69 – хроническое; у 149 пациентов – изолированный передний увеит (ПУ), у 59 – увеит с вовлечением задних отделов глаза; у 160 – односторонний увеит, у 48 – двусторонний; у 159 больных выявлен маркер HLA-В27. В результате обследования у 60 пациентов диагностированы различные варианты СпА; у 148 пациентов СпА не выявлен. Группы пациентов со СпА и без СпА сопоставлялись по полу, возрасту дебюта увеита, наличию HLA-В27, клиническим особенностям увеита.Результат. СпА диагностирован у 45 из 139 больных острым рецидивирующим увеитом (отношение шансов (ОШ) – 1,723; 95%-й доверительный интервал (95% ДИ): 0,879–3,379; р=0,113); у 15 из 69 больных хроническим увеитом (ОШ=0,597; 95% ДИ: 0,304–1,172; р=0,134); у 51 из 160 больрных односторонним увеитом (ОШ=2,028; 95% ДИ: 0,913–4,501; р=0,082); у 9 из 48 больных двусторонним увеитом (ОШ=0,493; 95% ДИ: 0,222–1,095; р=0,082); у 55 из 149 больрных изолированным ПУ (ОШ=6,319; 95% ДИ: 2,384–16,749; р=0,001); у 5 из 59 больных панувеитом (ОШ=0,158; 95% ДИ: 0,060–0,419; р=0,001); у 56 из 159 HLA-В27-позитивных пациентов (ОШ=6,117; 95% ДИ: 2,091–17,888; р=0,001). СпА диагностирован у 44 из 107 больных с дебютом увеита в возрасте не старше 30 лет (ОШ=3,710; 95% ДИ: 1,921–7,168; р=0,001). СпА также выявлен у 39 из 79 мужчин (ОШ=5,014; 95% ДИ: 2,637–9,535; р=0,001).Методом многофакторного пошагового дискриминантного анализа получена формула для определения вероятности СпА при увеите: 1,972 × Х1 + 1,476 × Х2 + 1,418 × Х3 + 1,270 × Х4 + 0,668 × Х5 + 0,162 × Х6, где: Х1 – мужской пол; Х2 – дебют увеита в возрасте не старше 30 лет, Х3 – наличие HLA-В27; Х4 – изолированный ПУ; Х5 – односторонний увеит; Х6 – острый рецидивирующий увеит. Если полученная сумма больше 4,552, вероятность СпА оценивается как высокая, при сумме меньше или равной 4,552 – как низкая.Вывод. Совокупность значимых клинических параметров (мужской пол, дебют увеита в возрасте не старше 30 лет, наличие HLA-В27, изолированный ПУ, одностороннее поражение, острое рецидивирующее течение) позволяет количественно определить риск СпА, что способствует своевременной постановке диагноза.</p></abstract><trans-abstract xml:lang="en"><p>Background. Uveitis is a heterogeneous group of inflammatory eye diseases, some of which may be associated with spondyloarthritis (SpA). The probability of SpA depends on the clinical features of uveitis.The aim – to develop a prognostic formula for determining the probability of spondyloarthritis in patients with uveitisMethods. 208 patients (pts) (79 men and 129 women) with different forms of uveitis, referred by ophthalmologists to the V.A. Nasonova Research Institute of Rheumatology, were assessed. The onset of uveitis at the age ≤30 years took place in 107/208 pts (51.44%), over 30 years – in 101 (48.56%). 139/208 pts had acute recurrent uveitis, 69 – chronic; 149 had isolated anterior uveitis (АU), 59 – posterior eye involvement, 160 had unilateral uveitis, 48 – bilateral; HLA-B27 was detected in 159 pts. Various SpA were identified in 60 cases and not confirmed in 148 pts. Groups of pts with and without SpA were compared by gender, age of uveitis onset, presence of HLA-B27, and clinical features of uveitis.Result. SpA was diagnosed in 45/139 pts with acute recurrent uveitis , and was not confirmed in 94/139 (odds ratio (OR) – 1.723; 95% confidence interval (95% CI): 0.879–3.379; p=0.113); SpA was confirmed in 15/69 pts with chronic uveitis, in 54/69 – with other forms of uveitis (OR=0.597; 95% CI: 0.304–1.172; p=0.134). SpA was diagnosed in 51/160 pts with unilateral uveitis and was not diagnosed in 109/160 (OR=2.028; 95% CI: 0.913–4.501; p=0.082); out of 48 pts with bilateral uveitis was 9 with SpA and 39 without SpA (OR=0.493; 95% CI: 0.222–1.095; p=0.082); among 149 pts with isolated AU – 55 with SpA and 94 without SpA (OR=6.319; 95% CI: 2.384–16.749; p=0.001); of 59 pts with panuveitis – 5 with SpA and 54 without SpA (OR=0.158; 95% CI: 0.060–0.419; p=0.001); among 159 HLA-B27-positive – 56 with SpA and 103 without SpA (OR=6.117; 95% CI: 2.091–17.888; p=0.001); the onset of uveitis at the age of ≤30 years was in 44/107 pts with SpA and in 63/107 – without SpA (OR=3.710; 95% CI: 1.921–7.168; p=0.001); SpA was confirmed in 39/79 male pts and was not confirmed in 40 (OR=5.014; 95% CI: 2.637–9.535; p=0.001).A formula to determine the probability of SpA in pts with uveitis was obtained by the method of multifactorial discriminant analysis: 1.972 × Х1 + 1.476 × Х2 + 1.418 × Х3 + 1.270 × Х4 + 0.668 × Х5 + 0.162 × Х6, where X1 – male; X2 – the onset of uveitis at the age of ≤30 years; X3 – HLA-B27; X4 – isolated anterior uveitis; X5 – unilateral uveitis; X6 – acute recurrent uveitis.If the amount is greater than 4.552, the probability of SpA is estimated as high, if the amount is less than or equal to 4.552, it is low.Conclusion. A combination of significant clinical parameters of uveitis (male, onset of uveitis at the age ≤30 years, HLA-B27, isolated anterior uveitis, unilateral lesion, acute recurrent course) allows to quantify the risk of SpA, that contributes to the timely diagnosis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>увеит</kwd><kwd>вероятность спондилоартрита</kwd></kwd-group><kwd-group xml:lang="en"><kwd>uveitis</kwd><kwd>probability of spondyloarthritis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509-516. doi: 10.1016/j.ajo.2005.03.057</mixed-citation><mixed-citation xml:lang="en">Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509-516. doi: 10.1016/j.ajo.2005.03.057</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Deschenes J, Murray PI, Rao NA, Nussenblatt RB; International Uveitis Study Group. International Uveitis Study Group (IUSG): Clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16(1):1-2. doi: 10.1080/09273940801899822</mixed-citation><mixed-citation xml:lang="en">Deschenes J, Murray PI, Rao NA, Nussenblatt RB; International Uveitis Study Group. International Uveitis Study Group (IUSG): Clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16(1):1-2. doi: 10.1080/09273940801899822</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Joltikov KA, Lobo-Chan AM. Epidemiology and risk factors in non-infectious uveitis: A systematic review. Front Med (Lausanne). 2021;8:695904. doi: 10.3389/fmed.2021.695904</mixed-citation><mixed-citation xml:lang="en">Joltikov KA, Lobo-Chan AM. Epidemiology and risk factors in non-infectious uveitis: A systematic review. Front Med (Lausanne). 2021;8:695904. doi: 10.3389/fmed.2021.695904</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Triggianese P, Fatica M, Caso F, Costa L, D’Antonio A, Tasso M, et al. Rheumatologist’s perspective on non-infectious uveitis: Patterns from tertiary referral rheumatologic clinics in Italy. Int J Mol Sci. 2023;24(11):9690. doi: 10.3390/ijms24119690</mixed-citation><mixed-citation xml:lang="en">Triggianese P, Fatica M, Caso F, Costa L, D’Antonio A, Tasso M, et al. Rheumatologist’s perspective on non-infectious uveitis: Patterns from tertiary referral rheumatologic clinics in Italy. Int J Mol Sci. 2023;24(11):9690. doi: 10.3390/ijms24119690</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2-16. doi: 10.1080/09273948.2016.1196713</mixed-citation><mixed-citation xml:lang="en">Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2-16. doi: 10.1080/09273948.2016.1196713</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;68(6):777-783. doi: 10.1136/ard.2009.108233</mixed-citation><mixed-citation xml:lang="en">Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;68(6):777-783. doi: 10.1136/ard.2009.108233</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Stübiger N, Farrokhi S, Gkanatsas Y, Deuter C, Kötter I. Clinical aspects, diagnostics and differential diagnostics of uveitis for rheumatologists. Z Rheumatol. 2022;81(7):587-595. doi: 10.1007/s00393-022-01243-z</mixed-citation><mixed-citation xml:lang="en">Stübiger N, Farrokhi S, Gkanatsas Y, Deuter C, Kötter I. Clinical aspects, diagnostics and differential diagnostics of uveitis for rheumatologists. Z Rheumatol. 2022;81(7):587-595. doi: 10.1007/s00393-022-01243-z</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for spondyloarthritis/HLA-B27-associated anterior uveitis. Am J Ophthalmol. 2021;228:117-125. doi: 10.1016/j.ajo.2021.03.049</mixed-citation><mixed-citation xml:lang="en">Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for spondyloarthritis/HLA-B27-associated anterior uveitis. Am J Ophthalmol. 2021;228:117-125. doi: 10.1016/j.ajo.2021.03.049</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández-Melón J, Muñoz-Fernández S, Hidalgo V, Bonilla-Hernán G, Schlincker A, Fonseca A, et al. Uveitis as the initial clinical manifestation in patients with spondyloarthropathies. J Rheumatol. 2004;31(3):524-527.</mixed-citation><mixed-citation xml:lang="en">Fernández-Melón J, Muñoz-Fernández S, Hidalgo V, Bonilla-Hernán G, Schlincker A, Fonseca A, et al. Uveitis as the initial clinical manifestation in patients with spondyloarthropathies. J Rheumatol. 2004;31(3):524-527.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Годзенко АА, Бочкова АГ, Румянцева ОА, Разумова ИЮ, Бадокин ВВ, Эрдес ШФ. Течение и исходы увеита у больных анкилозирующим спондилитом. Научно-практическая ревматология. 2014;52(5):520-526.</mixed-citation><mixed-citation xml:lang="en">Godzenko AA, Bochkova AG, Rumyantseva OA, Razumova IYu, Badokin VV, Erdes ShF. Progression and outcomes of uveitis in patients with ankylosing spondilitis. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2014;52(5):520-525 (In Russ.). doi: 10.14412/1995-4484-2014-520-525</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Дубинина ТВ, Демина АБ, Эрдес ШФ. НLА-В27-ассоциированные увеиты: эпидемиология, клиническая картина и осложнения. Научно-практическая ревматология. 2014;52(3):304-310.</mixed-citation><mixed-citation xml:lang="en">Dubinina TV, Demina AB, Erdes ShF. HLA-B27-associated uveitis: Epidemiology, clinical picture, and complications. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2014;52(3):304-310 (In Russ.). doi: 10.14412/1995-4484-2014-304-310</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Алекберова ЗС. Болезнь Бехчета. Лекция. Научно-практическая ревматология. 2013;51(1):52-58.</mixed-citation><mixed-citation xml:lang="en">Alekberova ZS. Behcet’s disease (a lecture). Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2013;51(1):52-58 (In Russ.). doi: 10.14412/1995-4484-2013-1202</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Лисицына ТА, Давыдова ГА, Хатагова ЗР, Катаргина ЛА, Алекберова ЗС. Оценка активности увеита с помощью индекса BOS24 у пациентов с болезнью Бехчета. Научно-практическая ревматология. 2016;54(6):681-686.</mixed-citation><mixed-citation xml:lang="en">Lisitsyna TA, Davydova GA, Khatagova ZR, Katargina LA, Alekberova ZS. Evaluation of uveitis activity using BOS24 in patients with Behсet’s disease. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2016;54(6):681-686 (In Russ.). doi: 10.14412/1995-4484-2016-681-686</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Smith JR, Rosenbaum JT. Management of uveitis: A rheumatologic perspective. Arthritis Rheumatol. 2002;46(2):309-18. doi: 10.1002/art.503</mixed-citation><mixed-citation xml:lang="en">Smith JR, Rosenbaum JT. Management of uveitis: A rheumatologic perspective. Arthritis Rheumatol. 2002;46(2):309-18. doi: 10.1002/art.503</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Rademacher J, Müllner H, Diekhoff T, Haibel H, Igel S, Pohlmann D, et al. Keep an eye on the back: Spondyloarthritis in patients with acute anterior uveitis. Arthritis Rheumatol. 2023;75(2):210-219. doi: 10.1002/art.42315</mixed-citation><mixed-citation xml:lang="en">Rademacher J, Müllner H, Diekhoff T, Haibel H, Igel S, Pohlmann D, et al. Keep an eye on the back: Spondyloarthritis in patients with acute anterior uveitis. Arthritis Rheumatol. 2023;75(2):210-219. doi: 10.1002/art.42315</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Chung YM, Liao HT, Lin KC, Lin YC, Chou CT, Chen CH, et al. Prevalence of spondyloarthritis in 504 Chinese patients with HLAB27-associated acute anterior uveitis. Scand J Rheumatol. 2009;38(2):84-90. doi: 10.1080/03009740802385423</mixed-citation><mixed-citation xml:lang="en">Chung YM, Liao HT, Lin KC, Lin YC, Chou CT, Chen CH, et al. Prevalence of spondyloarthritis in 504 Chinese patients with HLAB27-associated acute anterior uveitis. Scand J Rheumatol. 2009;38(2):84-90. doi: 10.1080/03009740802385423</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Huhtinen M, Karma A. HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population. Br J Ophthalmol. 2000;84(4):413-416. doi: 10.1136/bjo.84.4.413</mixed-citation><mixed-citation xml:lang="en">Huhtinen M, Karma A. HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population. Br J Ophthalmol. 2000;84(4):413-416. doi: 10.1136/bjo.84.4.413</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Sève P, Cacoub P, Bodaghi B, Trad S, Sellam J, Bellocq D, et al. Uveitis: Diagnostic work-up. A literature review and recommendations from an expert committee. Autoimmun Rev. 2017;16(12):1254-1264. doi: 10.1016/j.autrev.2017.10.010</mixed-citation><mixed-citation xml:lang="en">Sève P, Cacoub P, Bodaghi B, Trad S, Sellam J, Bellocq D, et al. Uveitis: Diagnostic work-up. A literature review and recommendations from an expert committee. Autoimmun Rev. 2017;16(12):1254-1264. doi: 10.1016/j.autrev.2017.10.010</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Haroon M, O’Rourke M, Ramasamy P, Murphy CC, FitzGerald O. A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: The DUET (Dublin Uveitis Evaluation Tool). Ann Rheum Dis. 2015;74(11):1990-1995. doi: 10.1136/annrheumdis-2014-205358</mixed-citation><mixed-citation xml:lang="en">Haroon M, O’Rourke M, Ramasamy P, Murphy CC, FitzGerald O. A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: The DUET (Dublin Uveitis Evaluation Tool). Ann Rheum Dis. 2015;74(11):1990-1995. doi: 10.1136/annrheumdis-2014-205358</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Годзенко АА, Разумова ИЮ, Бочкова АГ. Клиническая оценка увеита и ее значение в диагностике спондилоартритов. Научно-практическая ревматология. 2011;49(6):38-42.</mixed-citation><mixed-citation xml:lang="en">Godzenko AA, Razumova IYu, Bochkova AG. Clinical uveitis evaluation and its value in the diagnosis of spondyloarthritis. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2011;49(6):38-42 (In Russ.). doi: 10.14412/1995-4484-2011-519</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361-368. doi: 10.1002/art.1780270401</mixed-citation><mixed-citation xml:lang="en">van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361-368. doi: 10.1002/art.1780270401</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
